Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-09-12
2006-09-12
Spivack, Phyllis G. (Department: 1614)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
Reexamination Certificate
active
07105534
ABSTRACT:
Methods of using imidazo[1,2-α]pyridine ether compounds for modulating ion channel activity in a warm-blooded animal are disclosed.
REFERENCES:
patent: 4450164 (1984-05-01), Bristol et al.
patent: 4725601 (1988-02-01), Ueda et al.
patent: 0 033 094 (1984-10-01), None
patent: 0 261 912 (1988-03-01), None
patent: 0 204 285 (1992-01-01), None
patent: 0 596 406 (1994-05-01), None
Sanfilippo et al., J. Med. Chem., (1988), 31(11), 2221-7.
Asano, S., et al., “The C1-Channel in Hog Gastic Vesicles Is Part of the Function of H,K-ATPase”,J. Biol. Chem., vol. 252, No. 27, 1987 pp. 13263-13268.
Rizzi, C., et al., “Characterization of FR 172357, a new non-peptide bradykinihn B2 receptor antagonist, in human, pig and rabbit preparations”,Eur. J. Pharmacol, vol. 386, No. 1, 1999, pp. 25-31.
Beatch Gregory N.
Liu Yuzhong
Plouvier Bertrand M. C.
Cardiome Pharma Corp.
Seed IP Law Group PLLC
Spivack Phyllis G.
LandOfFree
Imidazo[1,2-α]pyridine ether compounds as ion channel... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Imidazo[1,2-α]pyridine ether compounds as ion channel..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Imidazo[1,2-α]pyridine ether compounds as ion channel... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3542055